Magenta Therapeutics, Inc.·4

Sep 16, 6:36 PM ET

COOKE MICHAEL P. 4

4 · Magenta Therapeutics, Inc. · Filed Sep 16, 2019

Insider Transaction Report

Form 4
Period: 2019-09-12
COOKE MICHAEL P.
Chief Scientific Officer
Transactions
  • Sale

    common stock

    2019-09-12$12.00/sh844$10,128264,679 total
Footnotes (1)
  • [F1]This trade is pursuant to an active 10b5-1 plan.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT